ArticleThe Indian journal of medical research2022

Replication of SARS-CoV-2 in cell lines used in public health surveillance programmes with special emphasis on biosafety.

Shailesh D Pawar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.